Results 101 to 110 of about 13,683 (246)

The Effectiveness of Medical Therapies for Joint, Skin and Eye Extraintestinal Manifestations in IBD—An Umbrella Review

Alimentary Pharmacology &Therapeutics, Volume 61, Issue 12, Page 1854-1871, June 2025.
Evidence for medical therapies targeting joint, skin and eye EIMs in IBD is heterogeneous and of low certainty. Multidisciplinary care and development of standardised, more appropriate outcome measures are essential to improve evaluation and guide future research. ABSTRACT Background Extraintestinal manifestations (EIMs) occur commonly in patients with
Olga M. Nardone, Nurulamin M. Noor, Aniruddh Prabhu, Alessandra Lim, Anirudh Krishnakumar, Abdulaziz Alajmi, Yuhong Yuan, Vipul Jairath, Maria Manuela Estevinho, Virginia Solitano   +9 more
wiley   +1 more source

Ankilozan Spondilit Hastalarında Yaşam Kalitesini ve Fonksiyonel Durumu Hangi Faktörler Etkiler?

Ankara Medical Journal, 2017
Giriş: Bu çalışma, Ankilozan spondilit (AS) hastalarında fonksiyonel durumu ve yaşam kalitesini etkileyen olası faktörleri belirlemek amacıyla yapıldı.Materyal ve Metot: Çalışmaya AS'li toplam 88 adet gönüllü Türk hasta dahil edildi.
Gülcan Gürer, Gülnur Taşçı Bozbaş, Ayşe İyiyapıcı Ünübol, Tiraje Tuncer, Bülent Bütün   +4 more
doaj   +1 more source

A Single Nucleotide Polymorphism in the Il17ra Promoter Is Associated with Functional Severity of Ankylosing Spondylitis [PDF]

, 2016
The aim of this study was to identify new genetic variants associated with the severity of ankylosing spondylitis (AS). We sequenced the exome of eight patients diagnosed with AS, selected on the basis of the severity of their clinical parameters.
Blanco García, Francisco Javier, Brüges Armas, Jácome, Coto García, Eliecer, Coto Segura, Pablo, Díaz Bulnes, P., Díaz Peña, Roberto, López Larrea, Carlos, López Vázquez, Antonio, Martínez Camblor, Pablo, Mulero, J., Pinto, José Antonio, Queiro Silva, Rubén, Sánchez, Alejandra, Vidal Castiñeira, José Ramón   +13 more
core   +6 more sources

Development of Extramusculoskeletal Manifestations in Upadacitinib‐Treated Patients With Psoriatic Arthritis or Axial Spondyloarthritis

Arthritis &Rheumatology, Volume 77, Issue 5, Page 536-546, May 2025.
Objective To assess the development of extramusculoskeletal manifestations (EMMs) among patients with psoriatic arthritis (PsA) or axial spondyloarthritis (axSpA) treated with upadacitinib 15 mg. Methods Data (cutoff: August 15, 2022) from five clinical trials in PsA (2), radiographic axSpA (r‐axSpA; previously ankylosing spondylitis) (2), and ...
Denis Poddubnyy, Bhumik Parikh, Dirk Elewaut, Victoria Navarro‐Compán, Stefan Siebert, Michael Paley, Derek Coombs, Ivan Lagunes, Ana Biljan, Priscila Nakasato, Peter Wung, Ennio Lubrano   +11 more
wiley   +1 more source

Serum chitotriosidase and neopterin levels in patients with ankylosing spondylitis

Therapeutic Advances in Musculoskeletal Disease, 2019
Background: The aim of this study was to assess the serum chitotriosidase (ChT) and neopterin levels in patients with ankylosing spondylitis (AS) and to evaluate whether serum ChT and neopterin levels are related to disease activity.
Ferdi Yavuz, Bilge Kesikburun, Özlem Öztürk, Ümüt Güzelküçük   +3 more
doaj   +1 more source

Randomized controlled trial of adalimumab in patients with nonpsoriatic peripheral spondyloarthritis [PDF]

, 2015
Objective. To evaluate the efficacy and safety of adalimumab in patients with active nonpsoriatic peripheral spondyloarthritis (SpA). Methods. ABILITY-2 is an ongoing phase III, multicenter study of adalimumab treatment.
Karunaratne, P Mahinda, Mease, Philip, Pangan, Aileen L, Rahman, Proton, Sieper, Joachim, Van den Bosch, Filip   +5 more
core   +1 more source

Real‐World Insights From Türkiye: Biologic DMARDs Usage in Spondyloarthritis Patients With Chronic Kidney Disease

International Journal of Rheumatic Diseases, Volume 28, Issue 5, May 2025.
ABSTRACT Aim The objective was to evaluate biologic disease‐modifying antirheumatic drugs (DMARDs) and their side effects that hindered the continuation of treatment in a patient population diagnosed with spondyloarthritis (SpA) with a glomerular filtration rate (GFR) ≤ 60 mL/min, and to compare these side effects between patients with chronic kidney ...
Dilara Bulut Gökten, Mehmet Engin Tezcan, Burcu Yağız, Abdulsamet Erden, Gezmiş Kimyon, Nazife Şule Yaşar Bilge, Levent Kılıç, Belkıs Nihan Coşkun, Emine Duygu Ersözlü, Orhan Küçükşahin, Süleyman Serdar Koca, Emel Gönüllü, Muhammet Çınar, Servet Akar, Hakan Emmungil, Timuçin Kaşifoğlu, Cemal Bes, Aşkın Ateş, Yavuz Pehlivan, Sedat Kiraz, Ali İhsan Ertenli, Hüseyin Ediz Dalkılıç, Umut Kalyoncu, Rıdvan Mercan   +23 more
wiley   +1 more source

Alternative to Rituximab Therapy for a Patient with Ankylosing Spondylitis Who Was Unable to Continue Anti-TNF Therapy [PDF]

, 2017
We herein present a case of a 38-year-old man who had bamboo spine and severe sacroiliitis and who was diagnosed with ankylosing spondylitis (AS).
Hiramatsu, Sumie, Katsuyama, Eri, Katsuyama, Takayuki, Kawabata, Tomoko, Miyawaki, Yoshia, Morishita, Michiko, Narazaki, Mariko, Ohashi, Keiji, Sada, Ken-ei, Tatebe, Noriko, Wada, Jun, Wakabayashi, Hiroshi, Watanabe, Haruki, Watanabe, Katsue S., Zeggar, Sonia   +14 more
core   +1 more source

POS0344 BASDAI CUT-OFFS FOR DISEASE ACTIVITY CORRESPONDING TO ASDAS-ESR CUT-OFFS IN AXIAL SPONDYLARTHRITIS – RESULTS FROM THE EUROSPA COLLABORATION [PDF]

, 2023
Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, Brigitte Michelsen, Tore K Kvien, Johan K. Wallman, Daniela Di Giuseppe, Karel Pavelká, Jakub Závada, Sella Aarrestad Provan, María José Santos, António Manuel Rodrigues, Adrian Ciurea, Michael J. Nissen, Cătălin Codreanu, Corina Mogoşan, Žiga Rotar, Matija Tomšič, Gary J. Macfarlane, Gareth T. Jones, Dan Nordström, Anna‐Mari Hokkanen, Irene van der Horst‐Bruinsma, Pasoon Hellamand, Mikkel Østergaard, Merete Lund Hetland   +24 more
openalex   +1 more source

Global Functioning in Axial Spondyloarthritis is Stronger Associated With Disease Activity and Function Than With Mobility and Radiographic Damage

Arthritis Care &Research, Volume 77, Issue 3, Page 385-392, March 2025.
Objective The Assessment of Spondyloarthritis International Society Health Index (ASAS HI) is a validated patient‐reported outcome (PRO) for global functioning of patients with axial spondyloarthritis (axSpA). The Epionics SPINE (ES) is an electronic device for assessment of axial mobility that provides an objective measure of spinal mobility by ...
David Kiefer, Jürgen Braun, Uta Kiltz, Varvara Chatzistefanidi, Daniela Adolf, Ilka Schwarze, Maria Kabelitz, Uwe Lange, Jan Brandt‐Jürgens, Edgar Stemmler, Sabine Sartingen, Xenofon Baraliakos   +11 more
wiley   +1 more source